| 07:00 | GSK | Transaction in Own Shares | RNS |
| 08.09.2025 07:00 | GSK | Transaction in Own Shares | RNS |
| 05.09.2025 07:00 | GSK | Transaction in Own Shares | RNS |
| 04.09.2025 15:30 | GSK | Director/PDMR Shareholding | RNS |
| 04.09.2025 07:00 | GSK | Transaction in Own Shares | RNS |
| 03.09.2025 07:00 | GSK | Transaction in Own Shares | RNS |
| 02.09.2025 07:00 | GSK | Transaction in Own Shares | RNS |
| 01.09.2025 15:00 | GSK | Total Voting Rights | RNS |
| 01.09.2025 07:00 | GSK | Transaction in Own Shares | RNS |
| 29.08.2025 07:00 | GSK | Transaction in Own Shares | RNS |
| 28.08.2025 07:00 | GSK | Transaction in Own Shares | RNS |
| 27.08.2025 07:00 | GSK | Transaction in Own Shares | RNS |
| 26.08.2025 07:00 | GSK | Transaction in Own Shares | RNS |
| 22.08.2025 07:00 | GSK | Transaction in Own Shares | RNS |
| 21.08.2025 15:30 | GSK | Director/PDMR Shareholding | RNS |
| 21.08.2025 07:00 | GSK | Transaction in Own Shares | RNS |
| 20.08.2025 07:00 | GSK | Transaction in Own Shares | RNS |
| 19.08.2025 15:30 | GSK | Director/PDMR Shareholding | RNS |
| 19.08.2025 07:00 | GSK | Transaction in Own Shares | RNS |
| 18.08.2025 07:00 | GSK | Transaction in Own Shares | RNS |
| 14.08.2025 07:00 | GSK | Transaction in Own Shares | RNS |
| 13.08.2025 10:19 | GSK, BLND | British Land signs new UK biotech and health startups for lab space | Alliance |
| 13.08.2025 07:00 | GSK | Transaction in Own Shares | RNS |
| 12.08.2025 15:30 | GSK | Director/PDMR Shareholding | RNS |
| 12.08.2025 07:00 | GSK | Transaction in Own Shares | RNS |
| 11.08.2025 08:40 | GSK | GSK's gepotidacin accepted for priority review by US FDA | Alliance |
| 11.08.2025 07:00 | GSK | FDA to review gonorrhea indication for gepotidacin | RNS |
| 11.08.2025 07:00 | GSK | Transaction in Own Shares | RNS |
| 08.08.2025 08:53 | GSK | GSK wins settlement, future royalties in CureVac mRNA patent dispute | Alliance |
| 08.08.2025 07:00 | GSK | CureVac/BioNTech mRNA patent litigation settlement | RNS |
| 08.08.2025 07:00 | GSK | Transaction in Own Shares | RNS |
| 07.08.2025 16:25 | ENRG, VSVS, ULVR | UK dividends calendar - next 7 days | Alliance |
| 07.08.2025 07:00 | GSK | Transaction in Own Shares | RNS |
| 06.08.2025 07:00 | GSK | Transaction in Own Shares | RNS |
| 05.08.2025 07:00 | GSK | Transaction in Own Shares | RNS |
| 04.08.2025 07:00 | GSK | Transaction in Own Shares | RNS |
| 01.08.2025 15:00 | GSK | Total Voting Rights | RNS |
| 01.08.2025 09:40 | POLR, RWA, LIO | LONDON BROKER RATINGS: Taylor Wimpey, Pets At Home, Just Group are cut | Alliance |
| 01.08.2025 07:00 | GSK | Transaction in Own Shares | RNS |
| 31.07.2025 07:00 | GSK | Transaction in Own Shares | RNS |
| 30.07.2025 09:01 | GSK | GSK eyes top-end annual results as second quarter beats expectations | Alliance |
| 30.07.2025 07:05 | GSK | Transaction in Own Shares | RNS |
| 30.07.2025 07:00 | GSK | 2nd Quarter Results | RNS |
| 29.07.2025 07:00 | GSK | Transaction in Own Shares | RNS |
| 28.07.2025 08:22 | GSK | GSK strikes USD12 billion drug portfolio deal with Hengrui Pharma | Alliance |
| 28.07.2025 07:00 | GSK | GSK enters Hengrui Pharma collaboration agreements | RNS |
| 28.07.2025 07:00 | GSK | Transaction in Own Shares | RNS |
| 25.07.2025 08:18 | GSK | GSK hails EU approval for blood cancer drug as US regulator wavers | Alliance |
| 25.07.2025 07:00 | GSK | Transaction in Own Shares | RNS |
| 24.07.2025 17:00 | GSK | Blenrep approved in the EU for multiple myeloma | RNS |
| 24.07.2025 07:00 | GSK | Transaction in Own Shares | RNS |
| 23.07.2025 19:52 | GSK | GSK says US FDA extends review period for Blenrep BLA until October | Alliance |
| 23.07.2025 17:00 | GSK | US FDA review extended for Blenrep | RNS |
| 23.07.2025 14:01 | SEPL, SWR, SGE | UK earnings, trading statements calendar - next 7 days | Alliance |
| 23.07.2025 07:00 | GSK | Transaction in Own Shares | RNS |
| 22.07.2025 07:00 | GSK | Transaction in Own Shares | RNS |
| 21.07.2025 09:33 | BHP, VAL, VALT | LONDON BROKER RATINGS: Stifel cuts Weir Group; BofA raises Pennon | Alliance |
| 21.07.2025 07:00 | GSK | Transaction in Own Shares | RNS |
| 18.07.2025 15:30 | GSK | Director/PDMR Shareholding | RNS |
| 18.07.2025 07:01 | GSK | Setback for GSK as Blenrep does not win US FDA committee support | Alliance |
| 18.07.2025 07:00 | GSK | Transaction in Own Shares | RNS |
| 18.07.2025 07:00 | GSK | Blenrep US ODAC outcome | RNS |
| 17.07.2025 09:56 | GSK | GSK wins US approval for prefilled syringe version of shingles vaccine | Alliance |
| 17.07.2025 07:00 | GSK | GSK’s Shingrix Fully Liquid FDA approval | RNS |
| 17.07.2025 07:00 | GSK | Transaction in Own Shares | RNS |
| 16.07.2025 07:00 | GSK | Transaction in Own Shares | RNS |
| 15.07.2025 15:30 | GSK | Director/PDMR Shareholding | RNS |
| 15.07.2025 07:00 | GSK | Transaction in Own Shares | RNS |
| 14.07.2025 15:30 | GSK | Director/PDMR Shareholding | RNS |
| 14.07.2025 08:21 | GSK | GSK seeks FDA green light for expanded use of RSV vaccine Arexvy | Alliance |
| 14.07.2025 07:00 | GSK | GSK submits Arexvy for adults 18-49 AIR to FDA | RNS |
| 14.07.2025 07:00 | GSK | Transaction in Own Shares | RNS |
| 11.07.2025 09:45 | GSK, NWG, LMP | LONDON BROKER RATINGS: Jet2 raised to 'buy'; Investec cuts Pagegroup | Alliance |
| 11.07.2025 07:00 | GSK | Transaction in Own Shares | RNS |
| 10.07.2025 07:00 | GSK | Transaction in Own Shares | RNS |
